cytarabine has been researched along with indomethacin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| D'Silva, JB; Notari, RE | 1 |
| Bálint, GA; Varró, V | 1 |
| Goto, M; Goto, MP; Hurley, RM; Picken, M; Zeller, WP | 1 |
| Albeck, M; Bruderman, I; Catane, R; Gafter, U; Gal, R; Kalechman, Y; Kaufman, B; Mettinger, KL; Shani, A; Shapira, J; Sredni, B; Tichler, T; Whisnant, JK; Xu, RH | 1 |
| Ault, P; Cortes, J; Kaled, ES; Kantarjian, H; Koller, C | 1 |
| Hwang, SY; Kim, HJ; Kim, SH; Kim, TS; Song, JH | 1 |
| Ahn, C; Choi, Y; Hong, EJ; Jeung, EB; Kang, HY; Yang, H | 1 |
| Ahn, C; Hong, EJ; Jeung, EB; Kang, HS; Kang, HY | 1 |
1 review(s) available for cytarabine and indomethacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cytarabine and indomethacin
| Article | Year |
|---|---|
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models.
Topics: Alopecia; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cytarabine; Cytokines; Dinoprostone; Ethylenes; Female; Humans; Indomethacin; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Lung Neoplasms; Macrophages; Male; Rats; Rats, Sprague-Dawley; Sialoglycoproteins | 1996 |
13 other study(ies) available for cytarabine and indomethacin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drug stability in liposomal suspensions: hydrolysis of indomethacin, cyclocytidine, and p-nitrophenyl acetate.
Topics: Ancitabine; Buffers; Cytarabine; Drug Stability; Hydrolysis; Indomethacin; Kinetics; Liposomes; Models, Chemical; Nitrophenols; Suspensions | 1982 |
Prostacyclin and DNA-synthesis inhibitors: their interaction on experimental gastric ulcer in the rat.
Topics: Animals; Cytarabine; DNA; Epoprostenol; Female; Indomethacin; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological | 1984 |
Lipopolysaccharide alters suckling rat liver glycogenolysis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Animals, Newborn; Cytarabine; Disease Models, Animal; Glycogen; Indomethacin; Isoquinolines; Kupffer Cells; Lipopolysaccharides; Liver; Piperazines; Rats; Rats, Sprague-Dawley; Shock, Septic; Tetradecanoylphorbol Acetate | 1993 |
Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate.
Topics: Alkylating Agents; Antimetabolites; Benzamides; Bone and Bones; Busulfan; Cladribine; Combined Modality Therapy; Consciousness Disorders; Cytarabine; Drug Resistance, Multiple; Enzyme Inhibitors; Fatal Outcome; Humans; Hydroxyurea; Hypereosinophilic Syndrome; Imatinib Mesylate; Immunosuppressive Agents; Indomethacin; Infarction; Male; Middle Aged; Mitral Valve Stenosis; Pancytopenia; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Splenectomy | 2002 |
Alleviation of the drug-resistant phenotype in idarubicin and cytosine arabinoside double-resistant acute myeloid leukemia cells by indomethacin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cytarabine; Drug Resistance, Neoplasm; Humans; Idarubicin; Indomethacin; Leukemia, Myeloid, Acute; Multidrug Resistance-Associated Proteins; Phenotype | 2008 |
Establishment of a rapid drug screening system based on embryonic stem cells.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Cytarabine; Dexamethasone; DNA Fragmentation; Drug Evaluation, Preclinical; Embryonic Stem Cells; Fluorouracil; Hydroxyurea; Indomethacin; Mice | 2015 |
Assessment of neurotoxicity of pharmacological compounds during early neural development of human embryonic stem cells.
Topics: Animals; Ascorbic Acid; Cell Differentiation; Cell Survival; Cells, Cultured; Cytarabine; Dexamethasone; Fluorouracil; Human Embryonic Stem Cells; Humans; Hydroxyurea; Indomethacin; Nestin; Neurogenesis | 2017 |